DNLI logo

Denali Therapeutics Inc. (DNLI) Depreciation and amortization

annual D&A:

$8.99M-$7.73M(-46.24%)
December 31, 2024

Summary

  • As of today (September 10, 2025), DNLI annual depreciation & amortization is $8.99 million, with the most recent change of -$7.73 million (-46.24%) on December 31, 2024.
  • During the last 3 years, DNLI annual D&A has risen by +$399.00 thousand (+4.64%).
  • DNLI annual D&A is now -46.24% below its all-time high of $16.73 million, reached on December 31, 2023.

Performance

DNLI Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIincome statement metrics

quarterly D&A:

$3.04M+$720.00K(+30.97%)
June 30, 2025

Summary

  • As of today (September 10, 2025), DNLI quarterly depreciation & amortization is $3.04 million, with the most recent change of +$720.00 thousand (+30.97%) on June 30, 2025.
  • Over the past year, DNLI quarterly D&A has increased by +$1.10 million (+56.80%).
  • DNLI quarterly D&A is now -66.79% below its all-time high of $9.17 million, reached on March 31, 2023.

Performance

DNLI quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIincome statement metrics

TTM D&A:

$9.06M+$1.10M(+13.86%)
June 30, 2025

Summary

  • As of today (September 10, 2025), DNLI TTM depreciation & amortization is $9.06 million, with the most recent change of +$1.10 million (+13.86%) on June 30, 2025.
  • Over the past year, DNLI TTM D&A has dropped by -$1.24 million (-12.05%).
  • DNLI TTM D&A is now -49.03% below its all-time high of $17.78 million, reached on September 30, 2023.

Performance

DNLI TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIincome statement metrics

DNLI Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.2%+56.8%-12.1%
3 y3 years+4.6%+147.2%+72.8%
5 y5 years+12.5%+42.0%+10.5%

DNLI Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-46.2%+4.6%-66.8%+147.2%-49.0%+77.2%
5 y5-year-46.2%+12.5%-66.8%+525.3%-49.0%+88.4%
alltimeall time-46.2%+7331.4%-66.8%+525.3%-49.0%+1220.8%

DNLI Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.04M(+31.0%)
$9.06M(+13.9%)
Mar 2025
-
$2.33M(+25.5%)
$7.96M(+2.1%)
Dec 2024
$8.99M(-46.2%)
$1.85M(+0.8%)
$7.79M(-4.0%)
Sep 2024
-
$1.84M(-5.4%)
$8.12M(-21.2%)
Jun 2024
-
$1.94M(-10.2%)
$10.30M(+6.0%)
Mar 2024
-
$2.16M(-0.7%)
$9.72M(-41.9%)
Dec 2023
$16.73M(+61.1%)
$2.18M(-45.9%)
$16.73M(-5.9%)
Sep 2023
-
$4.02M(+196.4%)
$17.78M(+18.3%)
Jun 2023
-
$1.36M(-85.2%)
$15.03M(+0.8%)
Mar 2023
-
$9.17M(+184.1%)
$14.91M(+112.0%)
Dec 2022
$10.38M(+20.8%)
$3.23M(+153.0%)
$7.03M(+37.5%)
Sep 2022
-
$1.28M(+3.6%)
$5.12M(-2.5%)
Jun 2022
-
$1.23M(-4.9%)
$5.24M(-4.4%)
Mar 2022
-
$1.30M(-1.1%)
$5.49M(-2.2%)
Dec 2021
$8.59M
$1.31M(-6.7%)
$5.61M(-2.1%)
Sep 2021
-
$1.41M(-4.8%)
$5.73M(+19.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
$1.48M(+4.2%)
$4.81M(-12.2%)
Mar 2021
-
$1.42M(-0.9%)
$5.48M(-11.2%)
Dec 2020
$8.53M(+6.8%)
$1.43M(+193.6%)
$6.17M(-9.2%)
Sep 2020
-
$487.00K(-77.3%)
$6.80M(-17.1%)
Jun 2020
-
$2.15M(+1.7%)
$8.20M(+6.5%)
Mar 2020
-
$2.11M(+2.6%)
$7.70M(-3.7%)
Dec 2019
$7.99M(+7.8%)
$2.06M(+8.7%)
$7.99M(-3.9%)
Sep 2019
-
$1.89M(+15.0%)
$8.31M(-5.0%)
Jun 2019
-
$1.64M(-31.6%)
$8.75M(-2.4%)
Mar 2019
-
$2.40M(+1.0%)
$8.96M(+20.9%)
Dec 2018
$7.42M(+140.6%)
$2.38M(+2.2%)
$7.42M(+26.9%)
Sep 2018
-
$2.33M(+25.4%)
$5.84M(+66.2%)
Jun 2018
-
$1.85M(+117.2%)
$3.52M(+111.7%)
Mar 2018
-
$854.00K(+5.8%)
$1.66M(+105.8%)
Dec 2017
$3.08M(+109.8%)
$807.00K(+17.6%)
$807.00K(+17.6%)
Dec 2016
$1.47M(+1114.0%)
$686.00K
$686.00K
Dec 2015
$121.00K
-
-

FAQ

  • What is Denali Therapeutics Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. annual D&A year-on-year change?
  • What is Denali Therapeutics Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. quarterly D&A year-on-year change?
  • What is Denali Therapeutics Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. TTM D&A year-on-year change?

What is Denali Therapeutics Inc. annual depreciation & amortization?

The current annual D&A of DNLI is $8.99M

What is the all time high annual D&A for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high annual depreciation & amortization is $16.73M

What is Denali Therapeutics Inc. annual D&A year-on-year change?

Over the past year, DNLI annual depreciation & amortization has changed by -$7.73M (-46.24%)

What is Denali Therapeutics Inc. quarterly depreciation & amortization?

The current quarterly D&A of DNLI is $3.04M

What is the all time high quarterly D&A for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high quarterly depreciation & amortization is $9.17M

What is Denali Therapeutics Inc. quarterly D&A year-on-year change?

Over the past year, DNLI quarterly depreciation & amortization has changed by +$1.10M (+56.80%)

What is Denali Therapeutics Inc. TTM depreciation & amortization?

The current TTM D&A of DNLI is $9.06M

What is the all time high TTM D&A for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high TTM depreciation & amortization is $17.78M

What is Denali Therapeutics Inc. TTM D&A year-on-year change?

Over the past year, DNLI TTM depreciation & amortization has changed by -$1.24M (-12.05%)
On this page